Skip to main content
placeholder image

Abandoning clinical trial safeguards won’t boost local industry

Journal Article


Download full-text (Open Access)

Abstract


  • CLINICAL TRIALS – Human clinical trials are an important last hurdle in the development of new drugs and therapies. Today, The Conversation takes a closer look at this vital scientific endeavour with three articles that look at different aspects of the process.

Authors


Publication Date


  • 2013

Citation


  • Komesaroff, P., Thomson, C. & Kerridge, I. (2013). Abandoning clinical trial safeguards won’t boost local industry. The Conversation, 7 October 1-4.

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=2889&context=smhpapers

Ro Metadata Url


  • http://ro.uow.edu.au/smhpapers/1871

Number Of Pages


  • 3

Start Page


  • 1

End Page


  • 4

Volume


  • 7 October

Place Of Publication


  • http://theconversation.com/abandoning-clinical-trial-safeguards-wont-boost-local-industry-14847

Abstract


  • CLINICAL TRIALS – Human clinical trials are an important last hurdle in the development of new drugs and therapies. Today, The Conversation takes a closer look at this vital scientific endeavour with three articles that look at different aspects of the process.

Authors


Publication Date


  • 2013

Citation


  • Komesaroff, P., Thomson, C. & Kerridge, I. (2013). Abandoning clinical trial safeguards won’t boost local industry. The Conversation, 7 October 1-4.

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=2889&context=smhpapers

Ro Metadata Url


  • http://ro.uow.edu.au/smhpapers/1871

Number Of Pages


  • 3

Start Page


  • 1

End Page


  • 4

Volume


  • 7 October

Place Of Publication


  • http://theconversation.com/abandoning-clinical-trial-safeguards-wont-boost-local-industry-14847